Stay updated on Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page version updated from v3.6.3 to v3.6.4. This reflects a backend or UI update to the study page rather than changes to the study data.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedA new bibliographic citation by Reike MJ et al. was added to Publications, detailing a 2024 Clin Genitourin Cancer article related to the PURE-01 study. The page revision was updated to v3.6.3.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a newer build of the page.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now indicates recruitment has closed and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment header formatting and the revision label to v3.6.0 (removing the previous v3.5.5).SummaryDifference0.5%

- Check53 days agoChange DetectedThe page's revision label updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a minor update to the Study Details page. This likely reflects small fixes or clarifications rather than changes to the trial information.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page revision tag advanced from v3.5.3 to v3.5.4, signaling a minor update to the study record display and related metadata.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page.